(Q42689637)

4 November 2017

Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety (English)

1 reference

4 November 2017

Weiss SM

1

1 reference

4 November 2017

Wadsworth G

series ordinal

2

1 reference

4 November 2017

Fletcher A

series ordinal

3

1 reference

4 November 2017

Dourish CT

series ordinal

4

1 reference

4 November 2017

1 January 1998

1 reference

Neuroscience & Biobehavioral Reviews

4 November 2017

1 reference

4 November 2017

23

1 reference

4 November 2017

2

1 reference

4 November 2017

265-271

1 reference

Antagonistic effects of caffeine and yohimbine in animal tests of anxiety.

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Use of the elevated plus maze in the search for novel anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Sodium valproate and chlordiazepoxide in the elevated plus-maze test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Some critical determinants of the behaviour of rats in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Animal models of anxiety: an ethological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900027-X

7 January 2021

10.1016/S0149-7634(98)00027-X

Identifiers

DOI

1 reference

4 November 2017

1 reference